Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene
The Journal of Clinical Endocrinology & Metabolism · 17.06.2024 · 109 (7) · 1726-1732
DOI: 10.1210/clinem/dgae040 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 23.01.2024. Verfasst von Wade Jodeh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Osteopetrosis, Mutation, Missense, Pedigree. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, Musculoskeletal Health Clinical Research Cores.
Abstract (Originalsprache)
Context
Autosomal dominant osteopetrosis (ADO) is a rare genetic disorder resulting from impaired osteoclastic bone resorption. Clinical manifestations frequently include fractures, osteonecrosis (particularly of the jaw or maxilla), osteomyelitis, blindness, and/or bone marrow failure. ADO usually results from heterozygous missense variants in the Chloride Channel 7 gene (CLCN7) that cause disease by a dominant negative mechanism. Variants in the T-cell immune regulator 1 gene (TCIRG1) are commonly identified in autosomal recessive osteopetrosis but have only been reported in 1 patient with ADO. Case Description Here, we report 3 family members with a single heterozygous missense variant (p.Gly579Arg) in TCIRG1 who have a phenotype consistent with ADO. Three of 5 protein prediction programs suggest this variant likely inhibits the function of TCIRG1.
Conclusion
This is the first description of adult presentation of ADO caused by a TCIRG1 variant. Similar to families with ADO from CLCN7 mutations, this variant in TCIRG1 results in marked phenotype variability, with 2 subjects having severe disease and the third having very mild disease. This family report implicates TCIRG1 missense mutations as a cause of ADO and demonstrates that the marked phenotypic variability in ADO may extend to disease caused by TCIRG1 missense mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Physical Therapy, Indiana University School of Health & Human Sciences, Indianapolis, IN 46202, USA.
- Department of Radiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Wade Jodeh, Steven Ing
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- Musculoskeletal Health Clinical Research Cores
- Valley of Indianapolis
- NIH HHS
- The Indiana Center
- The Indiana Clinical and Translational Sciences Institute
- Ancient Accepted Scottish Rite
Zitieren
APA
Jodeh, W., Katz, A. J., Hart, M., Warden, S. J., Niziolek, P., Alam, I., Ing, S., Polgreen, L. E., Imel, E. A., & Econs, M. J. (2024). Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene. The Journal of Clinical Endocrinology & Metabolism, 109(7), 1726-1732. https://doi.org/10.1210/clinem/dgae040
Vancouver
Jodeh W, Katz AJ, Hart M, Warden SJ, Niziolek P, Alam I, et al. Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene. The Journal of Clinical Endocrinology & Metabolism. 2024;109(7):1726-1732. doi:10.1210/clinem/dgae040
BibTeX
@article{Jodeh2024,
author = {Jodeh, Wade and Katz, Amy J and Hart, Marian and Warden, Stuart J and Niziolek, Paul and Alam, Imranul and Ing, Steven and Polgreen, Lynda E and Imel, Erik A and Econs, Michael J},
title = {Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {7},
pages = {1726--1732},
doi = {10.1210/clinem/dgae040}
}
EUVIMED